Overview

Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab

Status:
Recruiting

Trial end date:
2026-02-01

Target enrollment:

Participant gender:

Summary

A study on the effectiveness and safety of haploidentical hematopoietic stem cell transplantation in patients with MRD positive CD19+ ALL treated with conditioning regimens containing Blinatumomab

Phase:

Phase 1

Details

Lead Sponsor:

Zhejiang University

Treatments:

Blinatumomab